That's interesting.
We've heard that one of the reasons that CAMR has only been used once and that developing countries aren't coming to Canada to purchase more generic medications is that they can find them in other jurisdictions--like India and China--more cost effectively. So what circumstances existed in 2007 to allow this example to be cost effective?